Showing 3004 results
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LRThird quarterQ3 net sales grew +4% (cc¹, +4% USD), with core operating income¹ +10% (cc, +11% USD)Sales growth driven by priority brands including Kisqali (+…
-
Ad hoc release /Ad-hoc-Mitteilung gemäss Art. 53 KRDrittes QuartalDer Nettoumsatz stieg im dritten Quartal um +4% (kWk¹, +4% USD), das operative Kernergebnis¹ verbesserte sich um +10% (kWk, +11% USD)Das…
-
Biography /
-
Press release /Remibrutinib achieved significant and clinically meaningful reduction in relapses vs. teriflunomide, to approximately 1 relapse every 13 years, without the need for chronic B-cell depletion¹˒²MRI…
-
Clinical Trials /